Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Molecular Diagnostics"
DOI: 10.1080/14737159.2023.2192351
Abstract: ABSTRACT Introduction In the last decade, two new radionuclide-based therapies, 223Radichloride and radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA), have been approved by the regulatory authorities for the management of castrate-resistant prostate cancer (PCa).… read more here.
Keywords: prostate cancer; molecular metabolic; theranostics molecular; radiomics theranostics ... See more keywords
Molecular imprinting of glycoproteins: From preparation to cancer theranostics
Sign Up to like & getrecommendations! Published in 2022 at "Theranostics"
DOI: 10.7150/thno.69189
Abstract: Glycoprotein imprinted polymers have rapidly grown as excellent receptors for cancer targeting, diagnostics, inhibition, and nanomedicines as they specifically target glycans and glycosites overexpressed in various tumors. Compared to natural antibodies, they are easy to… read more here.
Keywords: cancer; theranostics molecular; imprinting glycoproteins; glycoprotein imprinted ... See more keywords